Showing results (241-250 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|October 24, 2025
Association between resection margin and local recurrence in the treatment of primary squamous cell vulvar carcinomaHein Hanna, Gasimli Khayal, Rödel Claus, et al.Journal of Gynecologic Oncology|September 19, 2025
Relationship between the lateral dissection lines of various radical hysterectomies and anatomical structures in the female pelvis: an educational video from the Sapporo Cadaver Surgical WorkshopHiroyuki Kanao, Masato Tamate, Motoki Matsuura, et al.Journal of Gynecologic Oncology|September 26, 2025
The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigationsSeiji Mabuchi, Naoko Komura, Harumi Nakamura, et al.Journal of Gynecologic Oncology|August 25, 2021
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic reviewViolante Di Donato, Giuseppe Caruso, Carolina Maria Sassu, et al.Journal of Gynecologic Oncology|August 25, 2021
Brachytherapy utilization rate and effect on survival in cervical cancer patients in KoreaYoung Ae Kim, Min Soo Yang, Minae Park, et al.Journal of Gynecologic Oncology|August 25, 2021
Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)Se Ik Kim, Jeong-Won Lee, Kidong Kim, et al.Journal of Gynecologic Oncology|July 18, 2025
Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial)Won Kyung Cho, Won Park, Jong Hoon Lee, et al.Journal of Gynecologic Oncology|July 4, 2025
UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2Guligeina Abudourexiti, Jingjing Zhang, Guzhanuer AbuduxikuerJournal of Gynecologic Oncology|July 1, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trialShin Nishio, Tadaaki Nishikawa, Masahiko Mori, et al.Journal of Gynecologic Oncology|July 1, 2025
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysisYong-Man Kim, Shin Nishio, Se Ik Kim, et al.Pageof 131